Abstract:Introduction: Out-of-hospital cardiac arrest (CA) is a leading cause of death with high mortality. Most patients die from post-CA syndrome due to ischemia/reperfusion injury-triggered responses. Taurine and glutamate, amino acids with cellular activities that are expressed primarily in heart and brain tissues, respectively, are released in response to CA. Hypothesis: Taurine and glutamate levels in blood reflect the extent of injury of CA. Taurine and glutamate could potentially regulate CA outcomes. Methods: Adult CA patients (n=51, 19 survivors, S and 32 nonsurvivors, NS; 35 received cooling treatment, C while 16 did not, NC) at an urban academic ED were enrolled from 2018-2019. Plasma taurine and glutamate collected at various time points including hospital arrival, 6, 24, 48 and 72 hours after arrival, and measured with commercially available assay kits. In a mouse model, 8-min asystolic cardiac arrest was induced with KCl, followed by initiation of CPR and randomized to blinded administration of taurine (50 mg/kg) or saline placebo at 90 second during CPR. Survival (4h) and mean arterial blood pressure (MAP) were evaluated. The Wilcoxon test and generalized estimating equation were used for comparison at each time point and longitudinal trend analysis for human data. Kaplan-Meier estimate and T-test were used for survival and mean comparison in mice. p <0.05 was considered statistically significant. Results: Plasma taurine and glutamate levels were highest at R0 and decreased over time in both S and NS, and were higher in NS than S. Taurine levels were significantly associated with survival (NS 66.24±41.36 vs. S 37.48±19.46 at 6h, p <0.05) while glutamate levels were not. Taurine levels in both C and NC groups demonstrated a significantly decreasing trend over time, but the C group showed more reduction ( p <0.05), while glutamate levels showed no significant trend. In mice, compared to saline, taurine treatment markedly improved 4h survival and MAP post-ROSC. Conclusions: Decreased release of taurine into blood is correlated with CA survival and may regulate CA outcomes. It has high translational potential as a biomarker for predicting CA survival, guiding cooling treatment, and serving as a therapeutic target to improve CA outcomes.

Taurine Detected Using High-Resolution Magic Angle Spinning (1)H Nuclear Magnetic Resonance: A Potential Indicator of Early Myocardial Infarction.

Myocardial Infarction Quantification with Late Gadolinium-Enhanced Magnetic Resonance Imaging in Rats Using a 7-T Scanner.

Alterations in Amino Acid Levels and Metabolite Ratio of Spinal Cord in Rat with Myocardial Ischemia-Reperfusion Injury by Proton Magnetic Resonance Spectroscopy.

An Experimental Proton Magnetic Resonance Spectroscopy Analysis on Early Stage of Acute Focal Cerebral Ischemia

Assessment of myocardial edema and area at risk in a rat model of myocardial infarction with a faster T2 mapping method.

Quantitative assessment of salvaged myocardial zone and intramyocardial hemorrhage using non-contrast faster T2 mapping in a rat model by 7T MRI.

The Value of Magnetic Resonance Spectroscopy in Diagnosing Myocardial Infarction

1H-MR Spectroscopy Changes in Transient Ischemic Attack Patients and Their Correlation with Perfusion-Weighted Imaging

Detecting Acute Myocardial Infarction by Diffusion-Weighted versus T2-Weighted Imaging and Myocardial Necrosis Markers.

Early metabolic changes following ischemia onset in rats: An in vivo diffusion-weighted imaging and 1H-magnetic resonance spectroscopy study at 7.0 T

Abstract 104: Taurine As Biomarker and Therapeutic Target for Cardiac Arrest

Low-dose Taurine Upregulates Taurine Transporter Expression in Acute Myocardial Ischemia.

Detecting early myocardial ischemia in rat heart by MALDI imaging mass spectrometry

Histological Validation of Cardiovascular Magnetic Resonance T1 Mapping for Assessing the Evolution of Myocardial Injury in Myocardial Infarction: an Experimental Study

Neurochemical Alterations of Different Cerebral Regions in Rats with Myocardial Ischemia-Reperfusion Injury Based on Proton Nuclear Magnetic Spectroscopy Analysis

Exploring diagnostic potentials of radioiodinated sennidin A in rat model of reperfused myocardial infarction

Evaluation of 1H MR Spectroscopy in Diagnosing Acute Cerebral Infarction

T2 Mapping at 7T MRI Can Quantitatively Assess Intramyocardial Hemorrhage in Rats with Acute Reperfused Myocardial Infarction in Vivo

The Correlation Analysis of Magnetic Resonance Spectroscopy (1HMRS) and Clinical Markers Before and after Treatment of Cerebral Infarction

[Tracking Early Reperfused Myocardial Infarction Using Cardiac MR].

MR Targeted Imaging for the Expression of Tenascin-C in Myocardial Infarction in Vivo.